Breaking News, Promotions & Moves

NeoImmuneTech Names New CEO

Luke Oh, Ph.D. will lead NeoImmuneTech from its Rockville headquarters and oversee all the operations in Korea.

Author Image

By: Charlie Sternberg

Associate Editor

NeoImmuneTech Inc., a clinical-stage T cell-focused biopharmaceutical company, has appointed Luke Oh, Ph.D. as President and Chief Executive Officer (CEO).   Having joined the company as President in January 2024, Oh succeeds Dr. Se Hwan Yang, Ph.D., as Chief Executive Officer of NeoImmuneTech, Inc. In his new role, he will lead NeoImmuneTech from its Rockville headquarters and overview all the operations in Korea. About Dr. Luke Oh Oh is an expert in regulatory policies and drug developm...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters